Antero Resources Corp <AR.N>: UBS Raises Target Price to $52 From $50
AR•Related News
Replimune more than doubles after FDA panel backs skin cancer drug
REPL•
Datavault AI schedules conference call on Q2 2026 results
DVLT•
Nasdaq Trade Halt Continues <NUTR.O> Reason Not Available at 10:23 AM
NUTR•
Lennox International Inc <LII.N>: Exane BNP Paribas cuts target price to $450 from $545
LII•
Nextpower Inc <NXT.O>: Jefferies cuts target price to $131 from $153
NXT•